Brian C. Thomas
CIK: 0001996097
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)3 (75.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (25.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MGX
Metagenomi, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Dec 5, 2025MGX
Metagenomi, Inc.
Sale(S)Direct3.8K shares at avg. $1.77$7K - Sep 5, 2025MGX
Metagenomi, Inc.
Sale(S)Direct2.7K shares at avg. $1.81$5K - Jun 6, 2025MGX
Metagenomi, Inc.
Sale(S)Direct10.8K shares at avg. $1.75$19K - Apr 1, 2025MGX
Metagenomi, Inc.
Award(A)Direct32K shares-
1-4 of 4 transactions
About Thomas Brian C.
Thomas Brian C. (SEC CIK 0001996097) files insider reports with the SEC as Chief Executive Officer of Metagenomi, Inc. (MGX).
Signal8 holds 4 ownership filings by Thomas Brian C., all Form 4s, filed between Apr 3, 2025 and Dec 8, 2025. Those filings report 4 transactions, from Apr 1, 2025 to Dec 5, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Thomas Brian C.'s filings is in EMERYVILLE, CA.
Recent filings by Thomas Brian C.
Other insiders filing for Metagenomi, Inc. (MGX)
- Reid Laurence, Director
- Wein Matthew
- Irish Jian
- Wapnick Pamela, Chief Financial Officer
- Dere Willard H, Director
- BJERKHOLT ERIC, Director